Drug Shortage Report for AMIKACIN SULFATE INJECTION USP

Last updated on 2021-11-03 History
Report ID 147920
Drug Identification Number 02242971
Brand name AMIKACIN SULFATE INJECTION USP
Common or Proper name AMIKACIN SO4
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMIKACIN
Strength(s) 250MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML 10LIVI
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-25
Estimated end date 2021-12-10
Actual end date
Shortage status Actual shortage
Updated date 2021-11-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-11-03 French Compare
v5 2021-11-03 English Compare
v4 2021-10-26 English Compare
v3 2021-10-25 French Compare
v2 2021-10-25 English Compare
v1 2021-10-25 English Compare